脆弱X综合征的iPSC模型反映了临床表型,并揭示了A介导的底层突触功能障碍的转录组失调
bioRxiv : the preprint server for biology
|October 28, 2024
概括
脆弱X综合征 (FXS) 涉及到FMR1基因沉默. 丧失FMRP蛋白质会破坏m6ARNA的修饰,导致突触缺陷,但m6A编写抑制在FXS中拯救了这些神经元问题.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 脆弱X综合征 (FXS) 是由于FMR1基因沉默和FMRP蛋白质损失导致智力障碍的主要遗传原因.
- N6-甲基氨酸 (m6A) 是一种关键的mRNA修饰,可以在转录后调节基因表达.
- FMRP与m6A修饰的转录相互作用,但其在FXS全球m6A变化中的作用尚不清楚.
研究的目的:
- 调查FMRP缺陷对脆弱X综合征中转录组范围的m6A修饰的影响.
- 探索m6A失调在FXS病变发生中的作用.
主要方法:
- 从健康个体和FXS患者的诱导多能干细胞 (iPSC) 生成的皮质神经元.
- 进行电生理学记录以验证神经网络缺陷.
- 分析了全转录组的m6A修饰和mRNA稳定性.
主要成果:
- 在FXS神经元中的FMRP缺陷增加了m6A"写字器",导致突触相关转录的高甲基化.
- 这种高甲基化导致mRNA衰变和突触缺陷的增加.
- 抑制m6A编辑器在FXS神经元中挽救了突触缺陷.
结论:
- 通过破坏的m6A修饰,FMRP依赖的表皮转录基因机制有助于FXS的致病性.
- 向m6A修改代表了脆弱X综合征的潜在治疗策略.
更多相关视频
11:10Dissecting Cell-Autonomous Function of Fragile X Mental Retardation Protein in an Auditory Circuit by In Ovo Electroporation
Published on: July 6, 2022
2.2K
10:59Generation and Characterization of Human Induced Pluripotent Stem Cell-derived Astrocytes Lacking Fragile X Messenger Ribonucleoprotein
Published on: June 6, 2025
42
相关概念视频
Chromatin Modification in iPS Cells
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
